Netanya-based Sync-Rx was founded in 2007. It will become a wholly-owned subsidiary of San Diego-based Volcano. Sync-Rx currently focuses on coronary catheterizations, and it plans to develop applications for structural heart disease. Volcano said that it plans to expand Sync-Rx's technology to work with real-time intra-body physiology measurements and intravascular ultrasound, intra-cardiac echocardiography, and optical coherence tomography imaging.
Volcano president and CEO Scott Huennekens said, "Sync-Rx's technology provides Volcano with a platform on which to build a range of advanced software features that will aid clinical decision-making by providing angiography and intra-body image enhancement, measurements and non-invasive imaging and intravascular co-registration capabilities, and future opportunities in physiology and peripheral and minimally invasive structural heart therapy guidance. We are excited about the Sync-Rx team joining Volcano and establishing a footprint in Israel, given the breadth and depth of medical imaging and software talent there."
Rafael and Sync-Rx chairman Ilan Biran said, "Sync-Rx's platform is another example of state-of-the-art technology developed in Israel that has demonstrated global superiority. For RDC, this is another success story which follows the successes of Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) and Medingo, which grew at RDC, achieved breakthroughs, and became leaders in their fields."
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments